BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9252721)

  • 21. [Compound therapy including PSK for malignant head and neck cancer].
    Hoshiya T; Matsunaga T; Hyo Y; Mori N; Kakiuchi H; Saeki K; Wakuda K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
    Nakazato H; Koike A; Saji S; Ogawa N; Sakamoto J
    Lancet; 1994 May; 343(8906):1122-6. PubMed ID: 7910230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A cooperative study of alternating immunochemotherapy with futraful and PSK (second report)--3-year survival rate].
    Ichihashi H; Kondo T; Yamauchi M; Isomatsu T; Nakamura T; Sakabe T; Nakajima T; Ikenaga T; Shiratori T; Taguchi T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):331-6. PubMed ID: 3918509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical effect of postoperative adjuvant immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients. Colorectal Cancer Chemotherapy Group in Hokuriku].
    Takashima S; Kinami Y; Miyazaki I
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2229-36. PubMed ID: 3136695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
    Nakazato H; Ichihashi H; Kondo T
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):308-18. PubMed ID: 3947108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of immunochemotherapy with PSK in malignant tumors of the female reproductive organs].
    Fujisawa S; Suzumori K; Yasui Y; Yamamoto T; Yagami Y
    Gan No Rinsho; 1986 Jan; 32(1):65-70. PubMed ID: 3485203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.
    Maehara Y; Inutsuka S; Takeuchi H; Baba H; Kusumoto H; Sugimachi K
    Cancer Chemother Pharmacol; 1993; 33(2):171-5. PubMed ID: 8261578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant PSK immunotherapy in patients with carcinoma of the nasopharynx.
    Go P; Chung CH
    J Int Med Res; 1989; 17(2):141-9. PubMed ID: 2656331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Krestin as adjuvant treatment following radical radiotherapy in non-small cell lung cancer patients.
    Hayakawa K; Mitsuhashi N; Saito Y; Nakayama Y; Furuta M; Nakamoto S; Kawashima M; Niibe H
    Cancer Detect Prev; 1997; 21(1):71-7. PubMed ID: 9043766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
    Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondou T; Abe O; Kikuchi K; Tanabe T; Ogawa N
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):799-806. PubMed ID: 2496668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan.
    Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
    Am J Clin Oncol; 1995 Jun; 18(3):216-22. PubMed ID: 7747709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of quality of treatment on prognosis in primary breast cancer patients treated in daily practice.
    Ottevanger PB; De Mulder PH; Grol RP; Van Lier H; Beex LV
    Anticancer Res; 2002; 22(1A):459-65. PubMed ID: 12017333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotypic and HLA studies in childhood acute lymphoblastic leukemia in Trinidad, West Indies.
    Cameron ES; Labastide WB; Wilson V; Charles W; Holder Y; Reid HF
    Leukemia; 1990 Sep; 4(9):615-9. PubMed ID: 2395381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of immunochemotherapy with Ftorafur and Krestin in rats.
    Takenoshita S; Hashizume T; Asao T; Morinaga N; Yajima Y; Shinozaki K; Shitara Y; Koitabashi H; Katou R; Nagamachi Y
    Anticancer Res; 1995; 15(1):147-51. PubMed ID: 7733625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
    Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
    Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of PSK on laryngeal cancer].
    Saito H; Hozawa J; Kamata S; Hakamada M; Kasahara M; Takagi A
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1061-7. PubMed ID: 7184440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A randomized controlled study of PSK combined immuno-chemotherapy for adenocarcinoma of the lung. The Advanced Lung Cancer Immuno-chemotherapy Study Group].
    Nishiwaki Y; Furuse K; Fukuoka M; Ota M; Niitani H; Asakawa M; Nakai H; Sakai S; Ogawa N
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):131-6. PubMed ID: 2404455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant hormone treatment and chemotherapy in postmenopausal women with operable breast cancer: a retrospective analysis.
    Oriana S; Coradini D; Sasso GM; Di Fronzo G
    Anticancer Res; 1991; 11(6):2199-205. PubMed ID: 1776861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.